• Facets (new session)
• Description
• Metadata
• Settings
  • Rule: ActivityStreamsMapasEquivalentb3sb3sifpdbprdf-labelfacetshttp://dbpedia.org/resource/inference/rules/dbpedia#http://dbpedia.org/resource/inference/rules/opencyc#http://dbpedia.org/resource/inference/rules/umbel#http://dbpedia.org/resource/inference/rules/yago#http://dbpedia.org/schema/property_rules#http://www.ontologyportal.org/inference/rules/SUMO#http://www.ontologyportal.org/inference/rules/WordNet#http://www.w3.org/2002/07/owl#ldpoplwebskos-transurn:det:rdf:labelvirtrdf-labelvirtrdf-urlNone
    
  • Inverse Functional Properties: Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects
  • "Same As": Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects (recommended) Apply to subjects, objects and predicates (not recommended on big datasets) Apply to predicates only (special use cases only)

About: dbr:Lapatinib     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : umbel-rc:DrugProduct, within Data Space : dbpedia.org associated with source document(s)

Type: Thingdul:ChemicalObjectchemical substancePill (pharmacy)yago:WikicatAminesyago:WikicatAnilinesyago:WikicatAromaticAminesyago:WikicatAromaticCompoundsyago:WikicatNitrogenHeterocyclesyago:Abstraction100002137yago:AliphaticCompound114601294yago:Amine114739004yago:Aniline114754505yago:AromaticCompound114610088yago:Base114618253yago:Chemical114806838yago:Compound114818238yago:Element114840755yago:Furan114876318yago:HeterocyclicCompound115025397yago:Hydrocarbon114911057yago:LanguageUnit106284225yago:Material114580897yago:Matter100020827yago:MethaneSeries114951377yago:Name106333653yago:OrganicCompound114727670yago:Part113809207yago:PhysicalEntity100001930yago:Pyrimidine114999913yago:Quintessence114847103yago:Relation100031921yago:WikicatFuransyago:WikicatGlaxoSmithKlineBrandsdrugyago:Substance100019613yago:TradeName106845599yago:WikicatPhenolEthersyago:WikicatPyrimidinesumbel-rc:DrugProduct New Facet based on Instances of this Class

Lapatinib (INN), used in the form of lapatinib ditosylate (USAN) (trade names Tykerb and Tyverb marketed by Novartis) is an orally active drug for breast cancer and other solid tumours. It is a dual tyrosine kinase inhibitor which interrupts the HER2/neu and epidermal growth factor receptor (EGFR) pathways. It is used in combination therapy for HER2-positive breast cancer. It is used for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2 (ErbB2).